Erasca

@Erasca

Erasca is a clinical-stage precision oncology company driven by a bold mission—to erase cancer by shutting down one of cancer's most commonly mutated pathways.

San Diego, CA

Joined July 2021

8 Following

146 Followers

10 Posts

Erasca retweeted

UT MD Anderson

@UTMDAnderson

almost 4 years ago

We’re proud to join Erasca in a strategic research and development collaboration to evaluate multiple agents from their pipeline targeting the RAS/MAPK pathway. Learn more: https://t.co/H6aV57LauB @Erasca @SKopetz @DavidHongMD #EndCancer

Erasca retweeted

LifeSci Advisors @LifeSciAdvisors

almost 4 years ago

Please join us for the @Erasca Virtual R&D Day on Lead Clinical Programs ERAS-007 & ERAS-601 in Advanced Solid Tumors featuring Dr. David Hong (MD Anderson Cancer Center). A live Q&A session will follow. Register Here: https://t.co/wcVbnN8jyD

LifeSciAdvisors's tweet photo. Please join us for the @Erasca Virtual R&D Day on Lead Clinical Programs ERAS-007 & ERAS-601 in Advanced Solid Tumors featuring Dr. David Hong (MD Anderson Cancer Center). A live Q&A session will follow. Register Here: https://t.co/wcVbnN8jyD https://t.co/0F0yeSgUnx

Erasca @Erasca

about 4 years ago

Please join us for this exciting event!

LifeSci Advisors @LifeSciAdvisors

about 4 years ago

Please join us on Tuesday, April 12th at 4:30 PM EDT for the @Erasca Investor Event featuring Scott Kopetz, M.D., Ph.D., (MD Anderson Cancer Center). A live Q&A session will follow. Register here: https://t.co/CsPgSdfHzA

LifeSciAdvisors's tweet photo. Please join us on Tuesday, April 12th at 4:30 PM EDT for the @Erasca Investor Event featuring Scott Kopetz, M.D., Ph.D., (MD Anderson Cancer Center). A live Q&A session will follow. Register here: https://t.co/CsPgSdfHzA https://t.co/kWWtaoUbWL

Erasca @Erasca

almost 5 years ago

@BIOCOMCEO @biocom @JLimMD Thank you @BIOCOMCEO for the kind words!

Who to follow

Dyne Therapeutics

@Dyne_tx

A clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases: https://t.co/0XslT2HWqg

TScan Therapeutics

@TScan_Tx

TScan is a fully integrated clinical-stage biotech company focused on developing a robust pipeline of TCR-T therapies for the treatment of patients with cancer

MeiraGTx

@MeiraGTx

MeiraGTx is committed to the development of novel genetic medicines to transform the lives of patients suffering from acquired and inherited disorders.

Erasca retweeted

Nasdaq Exchange

@NasdaqExchange

almost 5 years ago

A big, warm welcome to the @erascainc team! 👏👏👏 Erasca, Inc. joins us in Times Square to ring the @Nasdaq Opening Bell in honor of their IPO. 🎉 #EraseCancer

NasdaqExchange's tweet photo. A big, warm welcome to the @erascainc team! 👏👏👏

Erasca, Inc. joins us in Times Square to ring the @Nasdaq Opening Bell in honor of their IPO. 🎉 #EraseCancer https://t.co/ZMMUM7SDPx

Erasca retweeted

Nasdaq Exchange

@NasdaqExchange

almost 5 years ago

Welcome to the @Nasdaq family, @erascainc! Erasca, Inc. is a clinical-stage precision oncology company driven by a bold mission: to erase cancer by shutting down one of cancer's most commonly mutated pathways. #EraseCancer Now trading: $ERAS

NasdaqExchange's tweet photo. Welcome to the @Nasdaq family, @erascainc!

Erasca, Inc. is a clinical-stage precision oncology company driven by a bold mission: to erase cancer by shutting down one of cancer's most commonly mutated pathways. #EraseCancer

Now trading: $ERAS https://t.co/Rv3C1Dh3Wo

Erasca retweeted

Nasdaq Exchange

@NasdaqExchange

almost 5 years ago

.@erascainc is a clinical-stage precision oncology company driven by a bold mission—to erase cancer. We speak with CEO Jonathan E. Lim, M.D., about the company’s vision. https://t.co/MzN9mFg881